Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanobiosys is a molecular diagnostics company specializing in ultra-fast, point-of-care PCR technologies. The company's core platform, the UltraFast LabChip system, enables rapid genetic analysis by significantly reducing the time required for thermal cycling. Their product portfolio includes the Gene-Z, a handheld device designed for low-cost, mobile diagnostic testing in clinical and environmental settings. Nanobiosys focuses on applications in infectious disease detection, food safety, and personalized medicine. The technology is designed to be portable and high-throughput, catering to both laboratory and field-based diagnostic needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanobiosys.